Francesco Caponigro
National Tumor Institute
Naples
Italy
Name/email consistency: high
- Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors. Caponigro, F., Lorusso, D., Fornari, G., Barone, C., Merlano, M., Airoldi, M., Schena, M., MacArthur, R., Weitman, S., Jannuzzo, M.G., Crippa, S., Fiorentini, F., Petroccione, A., Comis, S. Cancer Chemother. Pharmacol. (2010)
- Treatment approaches to nasopharyngeal carcinoma: a review. Caponigro, F., Longo, F., Ionna, F., Perri, F. Anticancer. Drugs (2010)
- Docetaxel in the management of head and neck cancer. Caponigro, F., Longo, F., Perri, F., Ionna, F. Anticancer. Drugs (2009)
- An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer. Caponigro, F., Lacombe, D., Twelves, C., Bauer, J., Govaerts, A.S., Marréaud, S., Milano, A., Anthoney, A. Eur. J. Cancer (2009)
- A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck. Caponigro, F., Romano, C., Milano, A., Solla, R., Franchin, G., Adamo, V., Mari, E., Morrica, B., Pepe, S. Anticancer. Drugs (2008)
- Phase II study of rubitecan in recurrent or metastatic head and neck cancer. Caponigro, F., Cartenì, G., Droz, J.P., Milano, A., Davis, W.B., Pollard, P. Cancer Chemother. Pharmacol. (2008)
- Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents. Caponigro, F., Milano, A., Basile, M., Ionna, F., Iaffaioli, R.V. Curr. Opin. Oncol (2006)
- Epidermal growth factor receptor as a major anticancer drug target. Caponigro, F., Milano, A., Ottaiano, A., Iaffaioli, R.V. Expert Opin. Ther. Targets (2006)
- A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer. Caponigro, F., Willemse, P., Sorio, R., Floquet, A., van Belle, S., Demol, J., Tambaro, R., Comandini, A., Capriati, A., Adank, S., Wanders, J. Invest. New. Drugs (2005)
- New drugs in cancer therapy, National Tumor Institute, Naples, 17-18 June 2004. Caponigro, F., Basile, M., de Rosa, V., Normanno, N. Anticancer. Drugs (2005)
- Monoclonal antibodies targeting epidermal growth factor receptor and vascular endothelial growth factor with a focus on head and neck tumors. Caponigro, F., Formato, R., Caraglia, M., Normanno, N., Iaffaioli, R.V. Curr. Opin. Oncol (2005)
- Gastric cancer. Treatment of advanced disease and new drugs. Caponigro, F., Facchini, G., Nasti, G., Iaffaioli, R.V. Front. Biosci. (2005)
- Rationale and clinical validation of epidermal growth factor receptor as a target in the treatment of head and neck cancer. Caponigro, F. Anticancer. Drugs (2004)
- New cytotoxic and molecular-targeted therapies of head and neck tumors. Caponigro, F., Ionna, F., Comella, G. Curr. Opin. Oncol (2004)
- Farnesyl transferase inhibitors in clinical development. Caponigro, F., Casale, M., Bryce, J. Expert. Opin. Investig. Drugs (2003)









